Allogene Therapeutics, Inc. (ALLO)

Allogene Therapeutics Statistics

Total Valuation

ALLO has a market cap or net worth of $894.66 million. The enterprise value is $496.12 million.

Market Cap	894.66M
Enterprise Value	496.12M

Important Dates

The next estimated earnings date is Tuesday, May 12, 2026, after market close.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

ALLO has 243.78 million shares outstanding. The number of shares has increased by 13.25% in one year.

Current Share Class	243.78M
Shares Outstanding	243.78M
Shares Change (YoY)	+13.25%
Shares Change (QoQ)	+1.80%
Owned by Insiders (%)	6.46%
Owned by Institutions (%)	53.25%
Float	187.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.13
P/TBV Ratio	2.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.93, with a Debt / Equity ratio of 0.28.

Current Ratio	7.93
Quick Ratio	7.74
Debt / Equity	0.28
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-192.50

Financial Efficiency

Return on equity (ROE) is -53.42% and return on invested capital (ROIC) is -29.11%.

Return on Equity (ROE)	-53.42%
Return on Assets (ROA)	-26.82%
Return on Invested Capital (ROIC)	-29.11%
Return on Capital Employed (ROCE)	-53.97%
Weighted Average Cost of Capital (WACC)	6.51%
Revenue Per Employee	n/a
Profits Per Employee	-$1.26M
Employee Count	152
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +193.10% in the last 52 weeks. The beta is 0.54, so ALLO's price volatility has been lower than the market average.

Beta (5Y)	0.54
52-Week Price Change	+193.10%
50-Day Moving Average	2.31
200-Day Moving Average	1.55
Relative Strength Index (RSI)	78.12
Average Volume (20 Days)	7,666,809

Short Selling Information

The latest short interest is 32.06 million, so 13.15% of the outstanding shares have been sold short.

Short Interest	32.06M
Short Previous Month	24.42M
Short % of Shares Out	13.15%
Short % of Float	17.12%
Short Ratio (days to cover)	4.70

Income Statement

Revenue	n/a
Gross Profit	-150.15M
Operating Income	-206.93M
Pretax Income	-190.89M
Net Income	-190.89M
EBITDA	-194.57M
EBIT	-206.93M
Earnings Per Share (EPS)	-$0.87

Balance Sheet

The company has $250.21 million in cash and $83.25 million in debt, with a net cash position of $166.96 million or $0.68 per share.

Cash & Cash Equivalents	250.21M
Total Debt	83.25M
Net Cash	166.96M
Net Cash Per Share	$0.68
Equity (Book Value)	292.54M
Book Value Per Share	1.28
Working Capital	225.24M

Cash Flow

In the last 12 months, operating cash flow was -$149.25 million and capital expenditures -$386,000, giving a free cash flow of -$149.63 million.

Operating Cash Flow	-149.25M
Capital Expenditures	-386,000
Depreciation & Amortization	12.36M
Net Borrowing	n/a
Free Cash Flow	-149.63M
FCF Per Share	-$0.61

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ALLO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.25%
Shareholder Yield	-13.25%
Earnings Yield	-28.79%
FCF Yield	-22.57%

Analyst Forecast

The average price target for ALLO is $8.40, which is 128.88% higher than the current price. The consensus rating is "Buy".

Price Target	$8.40
Price Target Difference	128.88%
Analyst Consensus	Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1